Burkhard Göke focuses on Internal medicine, Endocrinology, Glucagon-like peptide-1, Glucagon and Insulin. His Internal medicine research incorporates themes from Gastroenterology and In vivo. Burkhard Göke combines subjects such as Receptor and Gastric emptying with his study of Endocrinology.
His Glucagon-like peptide-1 research includes themes of Gastric inhibitory polypeptide, Incretin and Cholecystokinin. His study in Glucagon is interdisciplinary in nature, drawing from both Secretin, Small intestine and Leptin. His work in Insulin covers topics such as Hormone which are related to areas like Appetite and Obesity.
Internal medicine, Endocrinology, Immunology, Gastroenterology and Cancer research are his primary areas of study. Internal medicine is often connected to Diabetes mellitus in his work. Endocrinology and Receptor are frequently intertwined in his study.
His research integrates issues of Crohn's disease, Gene, Inflammatory bowel disease and Ulcerative colitis in his study of Immunology. His work carried out in the field of Inflammatory bowel disease brings together such families of science as Single-nucleotide polymorphism, Genotype and NOD2. The study incorporates disciplines such as Pancreatic hormone and Peptide hormone in addition to Glucagon.
Burkhard Göke spends much of his time researching Internal medicine, Endocrinology, Cancer research, Immunology and Gastroenterology. His Internal medicine study combines topics from a wide range of disciplines, such as Oncology and Pathology. His Insulin, Incretin, Glucose tolerance test and Diabetes mellitus study, which is part of a larger body of work in Endocrinology, is frequently linked to Sleeve gastrectomy, bridging the gap between disciplines.
The Insulin study combines topics in areas such as Gastric emptying and Type 2 diabetes. His biological study spans a wide range of topics, including IRGM and Inflammatory bowel disease. The concepts of his Gastroenterology study are interwoven with issues in Number needed to screen and Retrospective cohort study.
His primary scientific interests are in Internal medicine, Immunology, Endocrinology, Sodium-iodide symporter and Gastroenterology. The various areas that Burkhard Göke examines in his Internal medicine study include Magnetic resonance imaging and Oncology. His Immunology research integrates issues from Genome-wide association study, Genetic association, Single-nucleotide polymorphism, Inflammatory bowel disease and Receptor complex.
His research combines Chronic bronchitis and Endocrinology. His Gastroenterology research incorporates themes from Colonoscopy and Intention-to-treat analysis. His Incretin research includes elements of Glucose tolerance test and Glucagon.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
R Göke;H C Fehmann;T Linn;H Schmidt.
Journal of Biological Chemistry (1993)
Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients
Christine Herrmann;Rüdiger Göke;Gerd Richter;Hans-C. Fehmann.
Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
R. Eissele;R. Göke;S. Willemer;H.-P. Harthus.
European Journal of Clinical Investigation (1992)
Glucagon-like peptide-1: a potent regulator of food intake in humans
J P Gutzwiller;B Göke;J Drewe;P Hildebrand.
Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
Hans-Christoph Fehmann;Rüdiger Göke;Burkhard Göke.
Endocrine Reviews (1995)
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
Jean-Pierre Gutzwiller;Jürgen Drewe;Burkhard Göke;Burkhard Göke;Harald Schmidt.
American Journal of Physiology-regulatory Integrative and Comparative Physiology (1999)
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.
Stephan Brand;Florian Beigel;Torsten Olszak;Kathrin Zitzmann.
American Journal of Physiology-gastrointestinal and Liver Physiology (2006)
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Kelly E. Mayo;Laurence J. Miller;Dominique Bataille;Stéphane Dalle.
Pharmacological Reviews (2003)
Gastric emptying and release of incretin hormones after glucose ingestion in humans.
Jörg Schirra;Martin Katschinski;Claudia Weidmann;Thomas Schäfer.
Journal of Clinical Investigation (1996)
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
A Graser;P Stieber;D Nagel;C Schäfer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: